Literature DB >> 23035594

Systemic delivery of antihypertensive drugs via skin.

Sevgi Güngör1, Yildiz Ozsoy.   

Abstract

Hypertension is a chronic disease with one of the highest chances of causing death, and long-term treatment is required. The antihypertensive drugs used in the treatment are generally administered orally. The limitations of the oral route make transdermal delivery of drugs more attractive. The transdermal route offers numerous advantages including avoidance of systemic first-pass metabolism and high patient compliance. The transdermal therapeutic systems, popularly known as 'patches', deliver drugs across the skin with a constant release rate. However, skin is a unique membrane having excellent barrier properties. Either chemical enhancers or physical methods such as iontophoresis and electroporation have been used to provide effective plasma drug concentrations. This review article focuses on the approaches to enhance skin permeability of antihypertensive drugs for the optimization of transdermal therapeutic systems of these drugs and the research studies intended for the optimization of transdermal dosage forms of antihypertensive drugs are summarized.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23035594

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  4 in total

Review 1.  Percutaneous Delivery of Antihypertensive Agents: Advances and Challenges.

Authors:  Kevin Ita; Sharon Ashong
Journal:  AAPS PharmSciTech       Date:  2020-01-06       Impact factor: 3.246

Review 2.  Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting.

Authors:  Brian C Palmer; Lisa A DeLouise
Journal:  Molecules       Date:  2016-12-15       Impact factor: 4.411

Review 3.  Systemic delivery of β-blockers via transdermal route for hypertension.

Authors:  Abdul Ahad; Fahad I Al-Jenoobi; Abdullah M Al-Mohizea; Naseem Akhtar; Mohammad Raish; Mohd Aqil
Journal:  Saudi Pharm J       Date:  2014-01-03       Impact factor: 4.330

4.  Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate.

Authors:  Abdul Ahad; Abdulmohsen A Al-Saleh; Abdullah M Al-Mohizea; Fahad I Al-Jenoobi; Mohammad Raish; Alaa Eldeen B Yassin; Mohd Aftab Alam
Journal:  Saudi Pharm J       Date:  2017-02-02       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.